申请人:Imperial Chemical Industries Limited
公开号:US04225602A1
公开(公告)日:1980-09-30
The invention concerns the novel amine 1-(2-chlorobenzyl)-1,2,3,6-tetrahydropyridine of the formula: ##STR1## and its pharmaceutically acceptable acid-addition salts, which have useful properties in inhibiting the aggregation of blood platelets, and are of application in the treatment or prophylaxis of thrombosis or occlusive vascular disease. The invention also provides pharmaceutical compositions of, and analogy processes for the manufacture of the amine of formula I, or a salt thereof.
这项发明涉及新型胺1-(2-氯苄基)-1,2,3,6-四氢吡啶的化学式:##STR1##及其药用可接受的酸盐,具有抑制血小板聚集的有用性质,并可应用于治疗或预防血栓形成或闭塞性血管疾病。该发明还提供了化学式I的胺或其盐的药物组合物,以及制造这种胺或其盐的类似方法。